FYI, ongoing big story on SRPT drug for DMD. Lots of controversy surrounding this with advocacy groups pushing FDA hard for ODD drug approval. However, the approval is being sought for a very small clinical trial (n=12) and murky data.
http://www.thestreet.com/story/1354...-s-eteplirsen-fda-advisory-panel-meeting.html
Sarepta Rare Disease Advisory Panel Meeting today
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $1.633K | 487.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 32189472 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126368541 | 15 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |